DGAP-Adhoc
Bayer Aktiengesellschaft: Bayer Board of Management plans to focus entirely on Life Science businesses
Bayer Aktiengesellschaft / Key word(s): Strategic Company Decision
18.09.2014 08:51
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Anzeige
Leverkusen, September 18, 2014
The Board of Management of Bayer AG plans to focus the Bayer Group entirely
on the Life Science businesses - HealthCare and CropScience - and float
MaterialScience on the stock market as a separate company. In this way
Bayer would position itself as a world-leading company in the field of
human, animal and plant health. The plans remain subject to the approval of
the Supervisory Board.
The Board of Management decided this on September 2, 2014. The Supervisory
Board of Bayer AG will discuss the plans at its meeting today, Thursday. It
is planned to release further information when the Supervisory Board has
reached its decision.
Contact:
Peter Dahlhoff, Bayer AG, Investor Relations, Phone: 0214-30-33022, e-mail:
peter.dahlhoff@bayer.com, Fax: +49-214-30-96-33022
---------------------------------------------------------------------------
Information and Explaination of the Issuer to this News:
Forward-Looking Statements
This Ad-hoc Statement may contain forward-looking statements based on
current assumptions and forecasts made by Bayer Group or subgroup
management. Various known and unknown risks, uncertainties and other
factors could lead to material differences between the actual future
results, financial situation, development or performance of the company and
the estimates given here. These factors include those discussed in Bayer's
public reports which are available on the Bayer website at www.bayer.com.
The company assumes no liability whatsoever to update these forward-looking
statements or to conform them to future events or developments.
18.09.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Bayer Aktiengesellschaft
Kaiser-Wilhelm-Allee 1
51373 Leverkusen
Germany
Phone: +49 (0)214 30-81 013
Fax: +49 (0)21430-9681013
E-mail:
Internet: www.bayer.com
ISIN: DE000BAY0017
WKN: BAY001
Indices: DAX, EURO STOXX 50, Stoxx 50
Listed: Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime
Standard), Hamburg, Hannover, München, Stuttgart; Terminbörse
EUREX; Madrid
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
The Board of Management of Bayer AG plans to focus the Bayer Group entirely
on the Life Science businesses - HealthCare and CropScience - and float
MaterialScience on the stock market as a separate company. In this way
Bayer would position itself as a world-leading company in the field of
human, animal and plant health. The plans remain subject to the approval of
the Supervisory Board.
The Board of Management decided this on September 2, 2014. The Supervisory
Board of Bayer AG will discuss the plans at its meeting today, Thursday. It
is planned to release further information when the Supervisory Board has
reached its decision.
Contact:
Peter Dahlhoff, Bayer AG, Investor Relations, Phone: 0214-30-33022, e-mail:
peter.dahlhoff@bayer.com, Fax: +49-214-30-96-33022
---------------------------------------------------------------------------
Information and Explaination of the Issuer to this News:
Forward-Looking Statements
This Ad-hoc Statement may contain forward-looking statements based on
current assumptions and forecasts made by Bayer Group or subgroup
management. Various known and unknown risks, uncertainties and other
factors could lead to material differences between the actual future
results, financial situation, development or performance of the company and
the estimates given here. These factors include those discussed in Bayer's
public reports which are available on the Bayer website at www.bayer.com.
The company assumes no liability whatsoever to update these forward-looking
statements or to conform them to future events or developments.
18.09.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Bayer Aktiengesellschaft
Kaiser-Wilhelm-Allee 1
51373 Leverkusen
Germany
Phone: +49 (0)214 30-81 013
Fax: +49 (0)21430-9681013
E-mail:
Internet: www.bayer.com
ISIN: DE000BAY0017
WKN: BAY001
Indices: DAX, EURO STOXX 50, Stoxx 50
Listed: Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime
Standard), Hamburg, Hannover, München, Stuttgart; Terminbörse
EUREX; Madrid
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte